Of the various factors regulating SARS-CoV-2 entry, TMPRSS2 is the most favorable candidate for transcriptional inhibition as TMPRSS2 is required for SARS-CoV-2 entry to host cells and its expression levels are linked with lung disease severity. This evidence concerns the gene TMPRSS2 and lung disorder.